TRAINING - MANAGEMENT OF OPIOID USE DISORDER - ETHOSCE
EthosCE health care is providing this information to update professionals on mental health issues to support continuing education of medical and mental health professionals. A formal needs assessment of the mental health community, current issues in mental health, and a hospital staff needs assessment are the indicators for the content of the Wednesday Lecture Series programs.
Participants should be able to describe current psychiatric diagnoses, analyze various treatments presented, and apply this knowledge in developing their own strategies for more effective management of patients. No special background is required for physicians attending these lectures.
To learn more about this activity, click here
- Social Workers
- Recognize the scope of the problem of Opioid Use Disorder.
- List 3 approaches to the pharmacological treatment of Opioid Use Disorder.
- Recognize the importance of pharmacotherapy in the management of Opioid Use Disorder.
EthosCE & Partners HealthCare
EthosCE Association holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with EthosCE's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers and speakers have been asked to disclose any relationship he /she or their spouse or partner has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture form any entity besides EthosCE Association, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.
Sunil Khushalani, M.D. reports having no financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. He will not discuss any medications, off-label uses or other medical products or services in this presentation.
Event Planners/Reviewers Disclosures:
The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Ellen Mongan, M.D., Caroline Cahn, LCSW-C,Tom Flis, LCPC, Faith Dickerson, Ph.D., Robert Roca, M.D., Drew Pate, M.D., Steven Sharfstein, M.D, Desmond Kaplan, M.D., Briana Riemer, M.D, Ernestine Crosby, APRN, Darby Subotich, RN, MSN, Rick Wallace, RN, MSN, Jacqueline Williams-Porter, RN, MBA, Jennifer Tornabene and Bonnie Katz.
Designated: 1.00 Participation Credits
- 1.00 ABIM MOC II
- 1.00 AMA PRA Category 1 Credit™